Author:
Jenke Dennis,Christiaens Piet,Heise Ted
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference16 articles.
1. Non-targeted analysis (NTA) and suspect screening analysis (SSA): a review of examining the chemical exposome;Manz;J. Exposure Sci. Environ. Epidemiol.,2023
2. Approaches for assessing performance of high‑resolution mass spectrometry–based non‑targeted analysis methods;Fisher;Anal. Bioanal. Chem.,2022
3. Chemical characterization and non-targeted analysis of medical device extracts: a review of current approaches, gaps, and emerging practices;Sussman;ACS Biomater. Sci. Eng.,2022
4. ISO 10993–18:2020E. Biological evaluation of medical devices — Part 18: Chemical characterization of medical device materials within a risk management process. International Organization for Standardization (ISO). Second edition, 2020-01.
5. Safety thresholds and best practices for extractables and leachables in orally inhaled and nasal drug products. Product Quality Research Institute (PQRI). 8 SEPTEMBER 2006. 〈https://pqri.org/wp-content/uploads/2015/08/pdf/LE_Recommendations_to_FDA_09–29-06.pdf〉.